DEF 14A

Company

ENDRA Life Sciences Inc.

Filed

June 25, 2024

Period of Report

August 6, 2024

Accession Number

0001654954-24-008176

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →